A clinically validated whole genome pipeline for structural variant detection and analysis

BACKGROUND: With the continuing decrease in cost of whole genome sequencing (WGS), we have already approached the point of inflection where WGS testing has become economically feasible, facilitating broader access to the benefits that are helping to define WGS as the new diagnostic standard. WGS pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Neerman, Nir, Faust, Gregory, Meeks, Naomi, Modai, Shira, Kalfon, Limor, Falik-Zaccai, Tzipora, Kaplun, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631445/
https://www.ncbi.nlm.nih.gov/pubmed/31307387
http://dx.doi.org/10.1186/s12864-019-5866-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631445/
https://www.ncbi.nlm.nih.gov/pubmed/31307387
http://dx.doi.org/10.1186/s12864-019-5866-z

Ejemplares similares